Piper Sandler Lowers ShockWave Medical (NASDAQ:SWAV) Price Target to $280.00
ShockWave Medical (NASDAQ:SWAV – Get Rating) had its price target decreased by Piper Sandler from $300.00 to $280.00 in a research report issued to clients and investors on Thursday, The Fly reports
ShockWave Medical (NASDAQ:SWAV) Shares Down 3.7% on Insider Selling
ShockWave Medical, Inc. (NASDAQ:SWAV – Get Rating)'s stock price traded down 3.7% on Friday after an insider sold shares in the company. The company traded as low as $185.59 and last traded at $187.3
Is ShockWave Medical (NASDAQ:SWAV) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Piper Sandler Adjusts ShockWave Medical's Price Target to $280 From $300, Keeps Overweight Rating
11:27 AM EST, 01/26/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Shockwave Medical Is Maintained at Overweight by Piper Sandler
Shockwave Medical Is Maintained at Overweight by Piper Sandler
Shockwave Medical Price Target Cut to $280.00/Share From $300.00 by Piper Sandler
ShockWave Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/26/2023 46.94% Piper Sandler $300 → $280 Maintains Overweight 01/06/2023 17.55% Morgan Stanley $290 → $
Piper Sandler Maintains Overweight on ShockWave Medical, Lowers Price Target to $280
Piper Sandler analyst Adam Maeder maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and lowers the price target from $300 to $280.
ShockWave Medical Price Target Lowered to $280 From $300 at Piper Sandler
ShockWave Medical, Inc. (NASDAQ:SWAV) Shares Bought by Raymond James Financial Services Advisors Inc.
Raymond James Financial Services Advisors Inc. grew its position in shares of ShockWave Medical, Inc. (NASDAQ:SWAV – Get Rating) by 39.7% during the third quarter, according to its most recent Form
Loading...
No Stock Yet